Los puntos clave no están disponibles para este artículo en este momento.
CAC may have the potential to help match statin therapy to absolute CVD risk. Across the spectrum of dyslipidemia, event rates similar to secondary prevention populations were observed for patients with CAC ≥ 100.
Martin et al. (Sun,) studied this question.